Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

A mutation in CLOCK leads to altered dopamine receptor function.

Spencer S, Torres-Altoro MI, Falcon E, Arey R, Marvin M, Goldberg M, Bibb JA, McClung CA.

J Neurochem. 2012 Oct;123(1):124-34. doi: 10.1111/j.1471-4159.2012.07857.x. Epub 2012 Jul 27.

3.

The dopaminergic stabilizers pridopidine and ordopidine enhance cortico-striatal Arc gene expression.

Waters S, Ponten H, Edling M, Svanberg B, Klamer D, Waters N.

J Neural Transm (Vienna). 2014 Nov;121(11):1337-47. doi: 10.1007/s00702-014-1231-1. Epub 2014 May 11.

PMID:
24817271
4.

Specific role of VTA dopamine neuronal firing rates and morphology in the reversal of anxiety-related, but not depression-related behavior in the ClockΔ19 mouse model of mania.

Coque L, Mukherjee S, Cao JL, Spencer S, Marvin M, Falcon E, Sidor MM, Birnbaum SG, Graham A, Neve RL, Gordon E, Ozburn AR, Goldberg MS, Han MH, Cooper DC, McClung CA.

Neuropsychopharmacology. 2011 Jun;36(7):1478-88. doi: 10.1038/npp.2011.33. Epub 2011 Mar 23.

5.

Restricting dopaminergic signaling to either dorsolateral or medial striatum facilitates cognition.

Darvas M, Palmiter RD.

J Neurosci. 2010 Jan 20;30(3):1158-65. doi: 10.1523/JNEUROSCI.4576-09.2010.

6.

Effects of Ca2+ antagonists on motor activity and the dopaminergic system in aged mice.

Kurosaki R, Akasaka M, Michimata M, Matsubara M, Imai Y, Araki T.

Neurobiol Aging. 2003 Mar-Apr;24(2):315-9.

PMID:
12498965
7.

Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity.

Gaugler MN, Genc O, Bobela W, Mohanna S, Ardah MT, El-Agnaf OM, Cantoni M, Bensadoun JC, Schneggenburger R, Knott GW, Aebischer P, Schneider BL.

Acta Neuropathol. 2012 May;123(5):653-69. doi: 10.1007/s00401-012-0963-y. Epub 2012 Feb 24.

PMID:
22361813
8.

Dopamine receptor-mediated regulation of neuronal "clock" gene expression.

Imbesi M, Yildiz S, Dirim Arslan A, Sharma R, Manev H, Uz T.

Neuroscience. 2009 Jan 23;158(2):537-44. doi: 10.1016/j.neuroscience.2008.10.044. Epub 2008 Nov 5.

9.
10.

Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors.

Anzalone A, Lizardi-Ortiz JE, Ramos M, De Mei C, Hopf FW, Iaccarino C, Halbout B, Jacobsen J, Kinoshita C, Welter M, Caron MG, Bonci A, Sulzer D, Borrelli E.

J Neurosci. 2012 Jun 27;32(26):9023-34. doi: 10.1523/JNEUROSCI.0918-12.2012.

11.

Daytime spikes in dopaminergic activity drive rapid mood-cycling in mice.

Sidor MM, Spencer SM, Dzirasa K, Parekh PK, Tye KM, Warden MR, Arey RN, Enwright JF 3rd, Jacobsen JP, Kumar S, Remillard EM, Caron MG, Deisseroth K, McClung CA.

Mol Psychiatry. 2015 Nov;20(11):1406-19. doi: 10.1038/mp.2014.167. Epub 2015 Jan 6. Erratum in: Mol Psychiatry. 2015 Nov;20(11):1479-80.

12.
13.

Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.

Napolitano F, Bonito-Oliva A, Federici M, Carta M, Errico F, Magara S, Martella G, Nisticò R, Centonze D, Pisani A, Gu HH, Mercuri NB, Usiello A.

J Neurosci. 2010 Aug 18;30(33):11043-56. doi: 10.1523/JNEUROSCI.1682-10.2010.

14.

Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice.

Kramer PF, Christensen CH, Hazelwood LA, Dobi A, Bock R, Sibley DR, Mateo Y, Alvarez VA.

J Neurosci. 2011 Jan 5;31(1):126-32. doi: 10.1523/JNEUROSCI.4287-10.2011.

15.

Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression.

Donovan DM, Miner LL, Perry MP, Revay RS, Sharpe LG, Przedborski S, Kostic V, Philpot RM, Kirstein CL, Rothman RB, Schindler CW, Uhl GR.

Brain Res Mol Brain Res. 1999 Nov 10;73(1-2):37-49.

PMID:
10581396
16.

Evidence of increased dopamine receptor signaling in food-restricted rats.

Carr KD, Tsimberg Y, Berman Y, Yamamoto N.

Neuroscience. 2003;119(4):1157-67.

PMID:
12831870
17.

Increased striatal dopamine turnover following acute administration of rotenone to mice.

Thiffault C, Langston JW, Di Monte DA.

Brain Res. 2000 Dec 8;885(2):283-8.

PMID:
11102582
18.

Brain dopamine D-2 receptor mechanisms in spontaneously hypertensive rats.

Van den Buuse M, Jones CR, Wagner J.

Brain Res Bull. 1992 Feb;28(2):289-97.

PMID:
1375862
19.

The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.

Walters DE, Howard SG.

Eur J Pharmacol. 1990 Aug 10;184(2-3):257-64.

PMID:
2150376
20.

Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice.

Gomez-Sintes R, Bortolozzi A, Artigas F, Lucas JJ.

Eur Neuropsychopharmacol. 2014 Sep;24(9):1524-33. doi: 10.1016/j.euroneuro.2014.07.004. Epub 2014 Jul 21.

PMID:
25088904

Supplemental Content

Support Center